Pharmacology of Immunotherapeutic Drugs 1st ed. 2020 [Kõva köide]

  • Formaat: Hardback, 395 pages, kõrgus x laius: 254x178 mm, 109 Tables, color; 118 Illustrations, color; XIX, 395 p. 118 illus. in color., 1 Hardback
  • Ilmumisaeg: 20-Nov-2019
  • Kirjastus: Springer Nature Switzerland AG
  • ISBN-10: 3030199215
  • ISBN-13: 9783030199210
Teised raamatud teemal:
  • Kõva köide
  • Hind: 97,35 EUR*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 121,69 EUR
  • Säästad 20%
  • Lisa soovinimekirja
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 2-4 nädalat peale raamatu väljaandmist.
  • Lisa ostukorvi
  • Kogus:
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Formaat: Hardback, 395 pages, kõrgus x laius: 254x178 mm, 109 Tables, color; 118 Illustrations, color; XIX, 395 p. 118 illus. in color., 1 Hardback
  • Ilmumisaeg: 20-Nov-2019
  • Kirjastus: Springer Nature Switzerland AG
  • ISBN-10: 3030199215
  • ISBN-13: 9783030199210
Teised raamatud teemal:

Medicine has entered a golden age in which therapeutic agents are becoming widely available due to advances in basic science and technology. As such, many drugs have been developed that target inflammatory processes and/or the immune system. This book is intended for health professionals examining the modulation of inflammation by immunotherapeutic drugs. 

The immune system fills the primordial role of host defense and resistance to infections with pathogenic microorganisms. Several hematopoietic-derived cells constituting the innate and adaptive immune systems cooperate to provide barriers for microbial colonization and/or promote pathogen destruction within the host. Conversely, many immune cells are also involved in the pathogenesis and propagation of chronic inflammatory diseases. 

The beginning of this book details various components of the immune system including the cell types, lymphoid tissues, soluble cytokines and surface molecules that are essential for host defense. Breakdowns in immune tolerance, or dysregulated immune responses to antigens derived from self tissues or innocuous sources, can lead to the development of autoimmunity or chronic inflammatory diseases. Pathophysiologic roles for the immune system are detailed in corresponding chapters on autoimmunity, epithelial surfaces (lungs, skin, intestine), and transplantation, with special emphasis placed on immunotherapeutic drug targets. The last section of the book focuses on treatments that stimulate our immune system to specifically target and fight infectious diseases and cancer.  In each chapter, the medications used to treat various diseases/conditions in terms of their mechanism of action and other pharmacologic properties are detailed. Chapters begin with a table showing drug names and classifications. The importance of basic science and clinical trials cannot be understated in the context of drug development.  As such, the discovery of certain medications that had a lasting impact in medicine and pharmacy are highlighted in chapter subsections named “Bench to Bedside.”  Several clinical applications of immunotherapeutic drugs are described within end-of -chapter case studies including practice questions. 

The Pharmacology of Immunotherapeutic Drugs is a reference for immunologists and clinicians (medical doctors, pharmacists, nurses) examining the modulation of inflammatory processes by a variety of medications targeting the cells and mediators of our immune system.?

Chapter 1: Overview of the Immune System and its Pharmacological TargetsClinton B. Mathias, Ph.D.Figure Contributions: Jeremy P. McAleer, Ph.D.Table contributions by Doreen E. Szollosi, Ph.D. and Jeremy P. McAleer, Ph.D.
Chapter 2: Modulation of the Innate Immune SystemDoreen E. Szollosi, Ph.D.Clinton B. Mathias, Ph.D.
Chapter 3: Modulation of the Adaptive Immune SystemDoreen E. Szollosi, Ph.D.Clinton B. Mathias, Ph.D.Jeremy P. McAleer, Ph.D.From Bench to Bedside by Daniella D'Aquino
Chapter 4: Respiratory Disorders of the Immune System and their Pharmacological TreatmentClinton B. Mathias Ph.D.Figure Contributions: Jeffrey Rovatti, Pharm.D., Dylan Krajewski, Jeremy McAleer, Ph.D.Table Contributions: Kaitlin Armstrong, Kelsey Leite
Chapter 5: Inflammation of the Skin and its therapeutic targetsClinton B. Mathias, Ph.D.From Bench to Bedside by Kaitlin Armstrong
Chapter 6: Inflammatory Diseases of the Gastrointestinal Tract and Pharmacological TreatmentsClinton B. Mathias, Ph.D.Jeremy P. McAleer, Ph.D.Doreen E. Szollosi, Ph.D.Cases by Charles Babcock, Pharm.D., CDE, BCACP
Chapter 7: Mechanisms of Autoimmunity and Pharmacologic TreatmentsDoreen E. Szollosi, Ph.D.Kirsten Hokeness, Ph.D.Mohammed K. Manzoor, Pharm.D.Cases by Michele Riccardi, Pharm.D., BCPS
Chapter 8: Transplantation: Immunologic Principles and Pharmacologic AgentsClinton B. Mathias, Ph.D.Jeremy P. McAleer, Ph.D.From Bench to Bedside by Kaitlin Armstrong and Charles Babcock, Pharm.D., CDE, BCACPCase by Elizabeth Cohen, Pharm.D., BCPS
Chapter 9: Immunopathogenesis, Immunization, and Treatment of Infectious DiseasesDoreen E. Szollosi, Ph.D. Clinton B. Mathias, Ph.D.Victoria Lucero, Pharm.D.Sunna Ahmad, Pharm.D.Jennifer Donato, Pharm.D.Case by Andrea L. Leschak, Pharm.D., BCGP
Chapter 10: Cancer Immunotherapy Doreen E. Szollosi, Ph.D.Shannon R. M. Kinney, Ph.D.A.R.M. Ruhul Amin, Ph.D.Ngumbah Chumbow, Pharm.D.Figure contributions by Jeremy P. McAleer, Ph.D.From Bench to Bedside by Kaitlin Armstrong Answer Key Glossary of Abbreviations and Terms Index
Dr. Clinton Mathias received his Ph.D. in Biomedical Sciences with a concentration in Immunology from the University of Connecticut, where he studied the role of innate immune cells in the modulation of allergic asthma. His postdoctoral work at Boston Children's Hospital and Harvard Medical School focused on elucidating mechanisms regulating mast cell homeostasis and function in models of IgE-dependent asthma and food allergy. He is a founding faculty member of the Western New England University College of Pharmacy, where he teaches immunology, infectious diseases, and the pharmacology of immunotherapeutic drugs. His research interests are aimed at examining the genetic and environmental factors that govern mast cell responses during allergic inflammation. Dr. Jeremy McAleer received his Ph.D. in Biomedical Science from the University of Connecticut where he studied the adjuvant effects of lipopolysaccharide on T cells. His postdoctoral work at Louisiana State University and the University of Pittsburgh focused on the regulation of pulmonary T cell immunity by commensal microbiota. In 2014, he joined the faculty at Marshall University School of Pharmacy in Huntington, WV, where he teaches immunology and pharmacology and conducts research on the regulation of T cell immunity by environmental factors. Dr. Doreen Szollosi received her Ph.D. in Pathobiology from Brown University where she studied immunosuppression and lymphocyte apoptosis in a mouse model of polymicrobial sepsis at Rhode Island Hospital in Providence. She is a founding faculty member of the University of Saint Joseph School of Pharmacy in Hartford, CT where she enjoys teaching pharmacy students about the pharmacology of antimicrobials as well as drugs that affect the immune system. Her current research interests include studying the mechanisms of novel anti-inflammatory agents with dual pro-inflammatory cytokine and chemokine suppressive effects.

Tellige see raamat tutvumiseks meie kauplusesse!Raekoja plats 11, 51004 Tartu

Juhul, kui soovite raamatuga enne ostu tutvuda, siis palun sisestaga allpool oma nimi ning e-mail.
Võimaluse korral tellime raamatu poodi ning teavitame ka teid, kui raamat on müügile jõudnud.

* - väljad on kohustuslikud